Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of Merestinib in Combination With LY2874455 in Relapsed or Refractory Acute Myeloid Leukemia

NCT03125239 is registered in ClinicalTrials.gov with Jacqueline Garcia, MD as lead sponsor.

NCT NCT03125239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03125239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of Merestinib in Combination With LY2874455 in Relapsed or Refractory Acute Myeloid Leukemia
Lead sponsor
Jacqueline Garcia, MD
Phase
Phase 1
Overall status
Completed
Start date
August 10, 2017
Completion date
June 1, 2020
Enrollment
16 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

refractory adult acute myeloid leukemia, relapsed adult acute myeloid leukemia